Back |
home / stock / sabs / sabs message board
Subject | By | Source | When |
---|---|---|---|
Historic short interest: | XenaLives | investorshub | 11/24/2021 10:02:36 PM |
Monoclonal antibodies vs polyclonal antibodies: | XenaLives | investorshub | 10/30/2021 11:36:53 AM |
Video on home page - not youtube so | XenaLives | investorshub | 10/30/2021 11:22:52 AM |
Big Cypress Acquisition Corp Announces Special Meeting of | XenaLives | investorshub | 10/30/2021 11:15:45 AM |
$SABS: Engineered Immunity | XenaLives | investorshub | 10/30/2021 11:10:57 AM |
News, Short Squeeze, Breakout and More Instantly...
SAB Biotherapeutics Inc. Company Name:
SABS Stock Symbol:
NASDAQ Market:
SAB Biotherapeutics Inc. Website:
SAB Biotherapeutics, Inc. (NASDAQ: SABS) is one of today's top gainers. The company's shares have moved 0% on the day to $2.77. SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advance...
New name, logo and website updates, stock symbol will remain SABS With new brand identity, SAB BIO continues drive towards serious unmet needs in type 1 diabetes MIAMI, June 20, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB...
MIAMI, June 18, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progre...